Mycobacteria and AIDS: treatment, prevention and future prospects.
Young
L S
LS
Kuzell Institute, San Francisco, CA.
Bermudez
L E
LE
Inderlied
C B
CB
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D024841:Fluoroquinolones; D006801:Humans; D018942:Macrolides; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000209:etiology*; D012294:Rifamycins / Q000627:therapeutic use; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D018942:Macrolides; D012294:Rifamycins